Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason D Weber

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Cancer|May 24, 2019
Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situYing Liu, Robert West, Jason D Weber, et al.
Molecular and Cellular Biology|June 12, 2019
DHX33 Interacts with AP-2β To Regulate <i>Bcl-2</i> Gene Expression and Promote Cancer Cell SurvivalJiuling Wang, Weimin Feng, Zhen Yuan, et al.
Molecular and Cellular Biology|October 16, 2004
ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathwaySuzanne N Brady, Yue Yu, Leonard B Maggi, et al.
Cancer Research|June 24, 2010
Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancerYiyu Dong, Aimin Li, Jianbo Wang, et al.
Breast Cancer Research : BCR|November 16, 2019
Associations of race and ethnicity with risk of developing invasive breast cancer after lobular carcinoma in situVanessa Dania, Ying Liu, Foluso Ademuyiwa, et al.
Current Medicinal Chemistry|July 14, 2007
Therapeutic targets in the ARF tumor suppressor pathwayAnthony J Saporita, Leonard B Maggi, Anthony J Apicelli, et al.
Plos One|August 4, 2012
Cathepsin K-Cre causes unexpected germline deletion of genes in miceCrystal L Winkeler, Raleigh D Kladney, Leonard B Maggi, et al.
Cancer Research|November 4, 2005
Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated gliomaBiplab Dasgupta, Yijun Yi, Balazs Hegedus, et al.
Cancer Research Communications|May 19, 2022
8-azaadenosine and 8-chloroadenosine are not selective inhibitors of ADARKyle A Cottrell, Luisangely Soto Torres, Michael G Dizon, et al.
Molecular and Cellular Biology|May 12, 2025
Elevated Type I Interferon Signaling Defines the Proliferative Advantage of ARF and p53 Mutant Tumor CellsAlex Mabry, Catherine E Kuzmicki, Angelina O'Brien, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Cancer|May 24, 2019
Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situYing Liu, Robert West, Jason D Weber, et al.
Molecular and Cellular Biology|June 12, 2019
DHX33 Interacts with AP-2β To Regulate <i>Bcl-2</i> Gene Expression and Promote Cancer Cell SurvivalJiuling Wang, Weimin Feng, Zhen Yuan, et al.
Molecular and Cellular Biology|October 16, 2004
ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathwaySuzanne N Brady, Yue Yu, Leonard B Maggi, et al.
Cancer Research|June 24, 2010
Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancerYiyu Dong, Aimin Li, Jianbo Wang, et al.
Breast Cancer Research : BCR|November 16, 2019
Associations of race and ethnicity with risk of developing invasive breast cancer after lobular carcinoma in situVanessa Dania, Ying Liu, Foluso Ademuyiwa, et al.
Current Medicinal Chemistry|July 14, 2007
Therapeutic targets in the ARF tumor suppressor pathwayAnthony J Saporita, Leonard B Maggi, Anthony J Apicelli, et al.
Plos One|August 4, 2012
Cathepsin K-Cre causes unexpected germline deletion of genes in miceCrystal L Winkeler, Raleigh D Kladney, Leonard B Maggi, et al.
Cancer Research|November 4, 2005
Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated gliomaBiplab Dasgupta, Yijun Yi, Balazs Hegedus, et al.
Cancer Research Communications|May 19, 2022
8-azaadenosine and 8-chloroadenosine are not selective inhibitors of ADARKyle A Cottrell, Luisangely Soto Torres, Michael G Dizon, et al.
Molecular and Cellular Biology|May 12, 2025
Elevated Type I Interferon Signaling Defines the Proliferative Advantage of ARF and p53 Mutant Tumor CellsAlex Mabry, Catherine E Kuzmicki, Angelina O'Brien, et al.
Pageof 6